Madrigal Pharmaceuticals, Inc. financial data

Symbol
MDGL on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Barr Harbor Drive, Suite 400, West Conshohocken, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
SYNTA PHARMACEUTICALS CORP (to 8/1/2016)
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 727 % +101%
Quick Ratio 8.64 %
Debt-to-equity 32.7 % -73.3%
Return On Equity -57.5 % +73.8%
Return On Assets -43.4 % +56.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.1M shares +3.61%
Common Stock, Shares, Outstanding 22M shares +10.7%
Entity Public Float 5.1B USD +61.5%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 21.3M shares +7.65%
Weighted Average Number of Shares Outstanding, Diluted 21.3M shares +7.65%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 62.2M USD
General and Administrative Expense 108M USD +125%
Operating Income (Loss) -498M USD -30.8%
Net Income (Loss) Attributable to Parent -466M USD -24.7%
Earnings Per Share, Basic -21.9 USD/shares -9.83%
Earnings Per Share, Diluted -21.9 USD/shares -9.83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 100M USD +0.1%
Cash, Cash Equivalents, and Short-term Investments 931M USD +46.9%
Accounts Receivable, after Allowance for Credit Loss, Current 53.8M USD
Inventory, Net 34.1M USD
Assets, Current 1.03B USD +62.1%
Property, Plant and Equipment, Net 2.19M USD +41%
Operating Lease, Right-of-Use Asset 2.4M USD +40.2%
Assets 1.04B USD +62.7%
Accounts Payable, Current 43.6M USD +55.5%
Employee-related Liabilities, Current 35M USD +105%
Accrued Liabilities, Current 125M USD +38.6%
Liabilities, Current 169M USD +42.8%
Operating Lease, Liability, Noncurrent 1.02M USD -14.2%
Liabilities 288M USD +22.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 468K USD 0%
Retained Earnings (Accumulated Deficit) -1.8B USD -34.9%
Stockholders' Equity Attributable to Parent 754M USD +86.1%
Liabilities and Equity 1.04B USD +62.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -149M USD -77.4%
Net Cash Provided by (Used in) Financing Activities 574M USD +989%
Net Cash Provided by (Used in) Investing Activities 98.1M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 22M shares +10.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 523M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 105M USD +5.11%
Deferred Tax Assets, Valuation Allowance 509M USD +32.8%
Deferred Tax Assets, Gross 509M USD +32.8%
Operating Lease, Liability 2M USD +16.8%
Payments to Acquire Property, Plant, and Equipment 357K USD +920%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -466M USD -24.9%
Lessee, Operating Lease, Liability, to be Paid 2.22M USD +19.4%
Operating Lease, Liability, Current 983K USD +86.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.07M USD +124%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.15M USD +22.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 221K USD +49.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 446K USD
Deferred Tax Assets, Operating Loss Carryforwards 214M USD +76.4%
Preferred Stock, Shares Issued 2.37M shares 0%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 2.37M shares 0%
Depreciation, Depletion and Amortization 168K USD +35.5%
Deferred Tax Assets, Net of Valuation Allowance 217K USD +85.5%
Share-based Payment Arrangement, Expense 79.9M USD +60.6%
Interest Expense 15.1M USD +45.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%